Skip to main content
Equibles
ACXP logo

ACXP · Acurx Pharmaceuticals, Inc. · Proposed Sales

Track ACXP — free

Use ACXP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.43 -0.01 (-0.35%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Aug 13, 2026
Market Cap
$7.48M
Shares
5.27M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1736243 CUSIP 00510M203 13F (30d) 13 filings 13 filers Visit website Investor relations